Annual CFI
-$258.02 M
-$216.83 M-526.36%
December 1, 2024
Summary
- As of March 10, 2025, JANX annual cash flow from investing activities is -$258.02 million, with the most recent change of -$216.83 million (-526.36%) on December 1, 2024.
- During the last 3 years, JANX annual CFI has risen by +$82.94 million (+24.33%).
- JANX annual CFI is now -542.83% below its all-time high of $58.27 million, reached on December 31, 2022.
Performance
JANX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$33.93 M
+$21.25 M+167.68%
December 1, 2024
Summary
- As of March 10, 2025, JANX quarterly cash flow from investing activities is $33.93 million, with the most recent change of +$21.25 million (+167.68%) on December 1, 2024.
- Over the past year, JANX quarterly CFI has stayed the same.
- JANX quarterly CFI is now at all-time high.
Performance
JANX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$258.02 M
+$22.80 M+8.12%
December 1, 2024
Summary
- As of March 10, 2025, JANX TTM cash flow from investing activities is -$258.02 million, with the most recent change of +$22.80 million (+8.12%) on December 1, 2024.
- Over the past year, JANX TTM CFI has stayed the same.
- JANX TTM CFI is now -483.98% below its all-time high of $67.20 million, reached on September 30, 2022.
Performance
JANX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
JANX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -526.4% | 0.0% | 0.0% |
| 3 y3 years | +24.3% | 0.0% | 0.0% |
| 5 y5 years | -100.0% | 0.0% | 0.0% |
JANX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -542.8% | +24.3% | at high | +117.8% | -484.0% | +27.3% |
| 5 y | 5-year | -542.8% | +24.3% | at high | +116.5% | -484.0% | +27.3% |
| alltime | all time | -542.8% | +24.3% | at high | +116.5% | -484.0% | +27.3% |
Janux Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$258.02 M(+526.4%) | $33.93 M(+167.7%) | -$258.02 M(-8.1%) |
| Sep 2024 | - | $12.67 M(-106.6%) | -$280.82 M(-20.9%) |
| Jun 2024 | - | -$190.88 M(+67.8%) | -$354.95 M(+142.8%) |
| Mar 2024 | - | -$113.74 M(-1122.5%) | -$146.19 M(+254.9%) |
| Dec 2023 | -$41.19 M(-170.7%) | $11.12 M(-118.1%) | -$41.19 M(-23.6%) |
| Sep 2023 | - | -$61.45 M(-443.8%) | -$53.92 M(-297.6%) |
| Jun 2023 | - | $17.87 M(-304.5%) | $27.29 M(+47.9%) |
| Mar 2023 | - | -$8.74 M(+444.9%) | $18.46 M(-68.3%) |
| Dec 2022 | $58.27 M | -$1.60 M(-108.1%) | $58.27 M(-13.3%) |
| Sep 2022 | - | $19.76 M(+118.6%) | $67.20 M(-142.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | $9.04 M(-70.9%) | -$158.11 M(-49.0%) |
| Mar 2022 | - | $31.07 M(+324.1%) | -$309.74 M(-9.2%) |
| Dec 2021 | -$340.96 M(<-9900.0%) | $7.33 M(-103.6%) | -$340.96 M(-2.1%) |
| Sep 2021 | - | -$205.54 M(+44.1%) | -$348.29 M(+144.0%) |
| Jun 2021 | - | -$142.60 M(>+9900.0%) | -$142.75 M(>+9900.0%) |
| Mar 2021 | - | -$153.00 K(<-9900.0%) | -$153.00 K(<-9900.0%) |
| Dec 2020 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2020 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2020 | - | $0.00 | $0.00 |
| Dec 2019 | $0.00 | - | - |
FAQ
- What is Janux Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Janux Therapeutics?
- What is Janux Therapeutics annual CFI year-on-year change?
- What is Janux Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Janux Therapeutics?
- What is Janux Therapeutics quarterly CFI year-on-year change?
- What is Janux Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Janux Therapeutics?
- What is Janux Therapeutics TTM CFI year-on-year change?
What is Janux Therapeutics annual cash flow from investing activities?
The current annual CFI of JANX is -$258.02 M
What is the all time high annual CFI for Janux Therapeutics?
Janux Therapeutics all-time high annual cash flow from investing activities is $58.27 M
What is Janux Therapeutics annual CFI year-on-year change?
Over the past year, JANX annual cash flow from investing activities has changed by -$216.83 M (-526.36%)
What is Janux Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of JANX is $33.93 M
What is the all time high quarterly CFI for Janux Therapeutics?
Janux Therapeutics all-time high quarterly cash flow from investing activities is $33.93 M
What is Janux Therapeutics quarterly CFI year-on-year change?
Over the past year, JANX quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Janux Therapeutics TTM cash flow from investing activities?
The current TTM CFI of JANX is -$258.02 M
What is the all time high TTM CFI for Janux Therapeutics?
Janux Therapeutics all-time high TTM cash flow from investing activities is $67.20 M
What is Janux Therapeutics TTM CFI year-on-year change?
Over the past year, JANX TTM cash flow from investing activities has changed by $0.00 (0.00%)